跳至主要内容
临床试验/NL-OMON52658
NL-OMON52658已完成4 期

A cluster Randomised Controlled Trial of the effectiveness, usability and acceptability of a smart inhaler programme in asthma patients: the ACCEPTANCE study - ACCEPTANCE study

eids Universitair Medisch Centrum0 个研究点目标入组 242 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
242

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age >= 18 years;
  • Doctor-diagnosed asthma (according to Dutch national primary care asthma
  • guidelines (NHG)) - route A and B; Self-reported asthma diagnosis (confirmed at
  • study end (T12) by GP) - route C;
  • Partially controlled or uncontrolled asthma (ACQ >= 0.75);
  • Use of Symbicort Turbuhaler maintenance therapy;
  • Being 'non-adherent' defined as an adherence rate (number of fully adherent
  • days / total number of days) of below 80% over the 3rd and 4th week of the
  • run-in period.

排除标准

  • Use of SMART regimen (Symbicort Maintenance And Reliever Therapy) by taking
  • Symbicort as reliever in response to symptoms;
  • Change in inhaled corticosteroids dose in the 4 weeks prior to run-in period;
  • Use of systemic corticosteroids in the 4 weeks prior to run-in period;
  • Current use of biologics, (anti-IL-5 en anti-IgE);
  • Diagnosis of COPD or other significant respiratory diseases;
  • Malignancy with life expectancy < 1 year;
  • Inability to understand Dutch.

研究者

相似试验